The JPIAMR Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing has published a Consensus Statement – Developmental Roadmap for antimicrobial susceptibility testing systems, in Nature, (October 17, 2018).
We are pleased to see Nature publishing a review and the statement of the working group organised by JPIAMR. The group has made a thorough analysis on barriers to timely develop and implement novel and rapid Antimicrobial Susceptibility Test (AST) platforms. Such technologies help to accelerate initiation of targeted antimicrobial therapies for patients with infections and could extend the use and lifespan of today’s narrow-spectrum antimicrobials. The roadmap outlines a way forward.
Please find the whole review and the Consensus Statement in Nature.
In addition, there is a Nature editorial commenting on the same work. We note the importance of the work expressed; “It’s a landmark effort and a triumph of cooperation and communication for the community. Now the hard work really begins: addressing the issues in the roadmap”, the editorial states. It also acknowledges that that speeding up tests that would deliver results in an hour would be a game- changer. “But why has that not happened yet?” asks the editorial.
Please find the whole editorial here.
Please view our interview with Dr. Till Bachmann, the coordinator of the working group.
AMR, Developmental Roadmap for Antimicrobial Susceptibility Testing Systems, Diagnostics, JPIAMR, Nature